The Reading Room
Medical Breakthroughs and Good News Make People Happy in 2026
In a trial involving 500 individuals diagnosed with advanced pancreatic cancer, the experimental drug daraxonrasib nearly doubled average survival time, extending it from 6.
Julian Adebayo·June 6, 2026
